AstraZeneca taps Emergent as U.S. partner for potential COVID-19 vaccine

AstraZeneca taps Emergent as U.S. partner for potential COVID-19 vaccine

AstraZeneca has inked manufacturing deals globally to meet its target of making 2 billion doses of the vaccine, including with two Bill Gates-backed ventures and a $1.2 billion agreement with the U.S. government. The company's vaccine is among the first to move into mid-stage trials and the first indication of its effectiveness would likely be available in June or July. There are no approved vaccines or treatments for COVID-19, the highly contagious respiratory illness caused by the novel coronavirus....

Oil Tumbles Below $37 as Fed Caution Weighs on Risk Sentiment

(Bloomberg) -- Oil plunged more than 7% in New York as the Federal Reserve forecast a long road to recovery for the U.S. economy and American crude inventories rose to a record.Futures fell below $37 a barrel. Fed Chairman Jerome Powell said the pandemic could inflict long-lasting damage on the economy and signaled it would keep rates near zero possibly for years to come, weighing on equity markets globally. There were also fears a second wave of infections in the U.S. may derail its fragile recovery. Meanwhile, American crude inventories rose unexpectedly last week, while gasoline stockpiles also saw a surprise increase.Global supply cuts and the easing of lockdowns in some countries have pushed prices higher after oil sank below zero in April. However, the demand recovery is uneven in Asia and there’s still a huge glut of oil stored both on land and at sea. In the U.S., a second...